Digital SMS intervention increases COVID-19 vaccine uptake in Hispanic children by 13 percentage points
A community-based randomized controlled trial evaluated a digital intervention to promote COVID-19 vaccination among Hispanic children. The study included 254 participants (126 intervention, 128 control) who were families with any unvaccinated children aged 17 years or younger, with a focus on children aged 5 to 11. The intervention group received 'MiVacunaLA/MyShotLA,' a fully automated program delivering three culturally and linguistically tailored educational SMS text messages weekly via a closed online platform, while the control group received no specific intervention.
The primary outcome was self-reported COVID-19 vaccine uptake among household children. The intervention resulted in a statistically significant absolute difference of 13.3 percentage points (95% CI 0.3% to 26.4%; P=.04) compared to control. A secondary outcome, caregiver trust in governmental vaccine approval processes for children, also showed a significant improvement, with a 14.3 percentage point difference (95% CI 0% to 23.7%; P=.003). Safety and tolerability data were not reported.
Key limitations include reliance on self-reported vaccination status without verification, which may introduce bias. The sample size was modest, and the confidence intervals for the primary outcome are wide, indicating uncertainty about the precise effect magnitude. The intervention was delivered in a specific community context to a Hispanic population, which may limit generalizability to other groups.
For practice, this trial provides preliminary evidence that a low-cost, scalable digital strategy using tailored SMS messaging can be associated with increased vaccine uptake and trust in a population with documented vaccination gaps. However, clinicians should interpret the self-reported vaccine uptake data cautiously and recognize that this single study does not establish the intervention's effectiveness in all settings or for other vaccines.